193
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

Galactosylated poly(ethylene glycol) methacrylate-st-3-guanidinopropyl methacrylamide copolymers as siRNA carriers for inhibiting Survivin expression in vitro and in vivo

, , , , , , , & show all
Pages 352-364 | Received 02 Jul 2013, Accepted 17 Dec 2013, Published online: 09 Jan 2014

References

  • Fire A, Xu S, Montgomery MK, et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998;391:806–11
  • Ginn SL, Alexander IE, Edelstein ML, et al. Gene therapy clinical trials worldwide to 2012 – an update. J Gene Med 2013;15:65–77
  • Lewis DL, Hagstrom JE, Loomis AG, et al. Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nat Genet 2002;32:107–8
  • Rose VL, Winkler S, Allen S, et al. Polymer siRNA conjugates synthesised by controlled radical polymerisation. Eur Polym J 2013;49:2861--83
  • De Smedt SC, Demeester J, Hennink WE. Cationic polymer based gene delivery systems. Pharm Res 2000;17:113–26
  • Pack DW, Hoffman AS, Pun S, Stayton PS. Design and development of polymers for gene delivery. Nat Rev Drug Discov 2005;4:581–93
  • Schimmer AD. Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice. Cancer Res 2004;64:7183--90
  • Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997;3:917–21
  • Samarajeewa S, Ibricevic A, Gunsten SP, et al. Degradable cationic shell cross-linked knedel-like nanoparticles: synthesis, degradation, nucleic acid binding, and in vitro evaluation. Biomacromolecules 2013;14:1018–27
  • Scholz C, Wagner E. Therapeutic plasmid DNA versus siRNA delivery: common and different tasks for synthetic carriers. J Control Release 2012;161:554–65
  • Rahmat D, Khan MI, Shahnaz G, et al. Synergistic effects of conjugating cell penetrating peptides and thiomers on non-viral transfection efficiency. Biomaterials 2012;33:2321–6
  • Kim TI, Ou M, Lee M, Kim SW. Arginine-grafted bioreducible poly(disulfide amine) for gene delivery systems. Biomaterials 2009;30:658–64
  • Funhoff AM, Van Nostrum CF, Lok MC, et al. Poly(3-guanidinopropyl methacrylate): a novel cationic polymer for gene delivery. Bioconjug Chem 2004;15:1212–20
  • Choi JS, Nam K, Park JY, et al. Enhanced transfection efficiency of PAMAM dendrimer by surface modification with L-arginine. J Control Release 2004;99:445–56
  • Nimesh S, Chandra R. Guanidinium-grafted polyethylenimine: an efficient transfecting agent for mammalian cells. Eur J Pharm Biopharm 2008;68:647–55
  • Qin Z, Liu W, Li L, et al. Galactosylated N-2-hydroxypropyl methacrylamide-b-N-3-guanidinopropyl methacrylamide block copolymers as hepatocyte-targeting gene carriers. Bioconjug Chem 2011;22:1503–12
  • Steinhauer W, Hoogenboom R, Keul H, Moeller M. Copolymerization of 2-hydroxyethyl acrylate and 2-methoxyethyl acrylate via RAFT: kinetics and thermoresponsive properties. Macromolecules 2010;43:7041–7
  • Wörz A, Berchtold B, Moosmann K, et al. Protein-resistant polymer surfaces. J Mater Chem 2012;22:19547–61
  • Whitehead KA, Langer R, Anderson DG. Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov 2009;8:129–38
  • Zhang F, Kang ET, Neoh KG, et al. Surface modification of stainless steel by grafting of poly(ethylene glycol) for reduction in protein adsorption. Biomaterials 2001;22:1541–8
  • Arakawa T, Timasheff SN. Mechanism of polyethylene glycol interaction with proteins. Biochemistry 1985;24:6756–62
  • Stadler V, Kirmse R, Beyer M, et al. PEGMA/MMA copolymer graftings: generation, protein resistance, and a hydrophobic domain. Langmuir 2008;24:8151–7
  • Lin WJ, Chen TD, Liu CW. Synthesis and characterization of lactobionic acid grafted pegylated chitosan and nanoparticle complex application. Polymer 2009;50:4166–74
  • Liu L, Zheng M, Renette T, Kissel T. Modular synthesis of folate conjugated ternary copolymers: polyethylenimine-graft-polycaprolactone-block-poly(ethylene glycol)-folate for targeted gene delivery. Bioconjug Chem 2012;23:1211--20
  • Zhang P, Hu L, Yin Q, et al. Transferrin-conjugated polyphosphoester hybrid micelle loading paclitaxel for brain-targeting delivery: synthesis, preparation and in vivo evaluation. J Control Release 2012;159:429--34
  • Kunath K, Merdan T, Hegener O, et al. Integrin targeting using RGD-PEI conjugates for in vitro gene transfer. J Gene Med 2003;5:588–99
  • Minko T. Receptor mediated delivery systems for cancer therapeutics. Fundam Appl Control Release Drug Deliv 2012;12:329–55
  • Jiang HL, Kwon JT, Kim EM, et al. Galactosylated poly (ethylene glycol)-chitosan-graft-polyethylenimine as a gene carrier for hepatocyte-targeting. J Control Release 2008;131:150–7
  • Varkouhi AK, Mountrichas G, Schiffelers RM, et al. Polyplexes based on cationic polymers with strong nucleic acid binding properties. Eur J Pharmal Sci 2011;45:459--66
  • Smith DD, Holley AC, Mccormick CL. RAFT-synthesized copolymers and conjugates designed for therapeutic delivery of siRNA. Polym Chem 2011;2:1428--41
  • Mitsukami Y, Donovan MS, Lowe AB, Mccormick CL. Water-soluble polymers. 81. Direct synthesis of hydrophilic styrenic-based homopolymers and block copolymers in aqueous solution via RAFT. Macromolecules 2001;34:2248–56
  • Cook SE, Park IK, Kim EM, et al. Galactosylated polyethylenimine-graft-poly (vinyl pyrrolidone) as a hepatocyte-targeting gene carrier. J Control Release 2005;105:151–63
  • Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 2012;64:61--71
  • Kircheis R, Wightman L, Schreiber A, et al. Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application. Gene Ther 2001;8:28–40
  • Kichler A. Gene transfer with modified polyethylenimines. J Gene Med 2004;6:S3–10
  • Reynolds A, Leake D, Boese Q, et al. Rational siRNA design for RNA interference. Nat Biotechnol 2004;22:326–30
  • Yonesaka K, Tamura K, Kurata T, et al. Small interfering RNA targeting survivin sensitizes lung cancer cell with mutant p53 to adriamycin. Int J Cancer 2006;118:812–20

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.